Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCOTROC 4: Carboplatin Dosing Strategies in Ovarian Cancer
NCT00098878Phase 3Completed
- Sponsor
- NHS Greater Glasgow and Clyde
- Start
- Mar 2004
- Primary completion
- Jul 2010
- Modality
- DNA Intercalators/Alkylators
- Countries
- 3
01
Overview
Phase 3, randomised, open-label trial of carboplatin in ovarian cancer, fallopian tube cancer (PFTC) and primary peritoneal cancer (PPC) (2 arms), sponsored by NHS Greater Glasgow and Clyde. Primary endpoint: Progression-Free Survival. Started Mar 2004; status: completed.
02
Drugs
carboplatin
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00098878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00098878.